Comparison of prostate health index and PCA3 values in patients with clinical or biologic suspicion of prostate cancer.

被引：0
|
作者：
Lamy, Pierre-Jean
Leizour, Benoit
Castan, Florence
Montels, Frederic
Laberenne, Anne-Claire
Roques, Sylvie
Ayuso, Didier
Abd El Fattah, Vincent
Abdel-Hamid, Samer
Faix, Antoine
Segui, Bruno
Azria, David
Rebillard, Xavier
机构：
[1] Inst Reg Canc Montpellier, Montpellier, France
[2] Clin Beausoleil, Montpellier, France
[3] Inst Canc Montpellier, Biometr Dept, Montpellier, France
[4] CH Bassin Thau, Sete, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.5055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5055
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Molecular bases and clinical applications of prostate cancer antigen 3 (PCA3) determination
    Ferrari, Maurizio
    Spiga, Ivana
    BIOCHIMICA CLINICA, 2011, 35 (05) : 356 - 362
  • [42] Clinical evaluation of prostate cancer 3 (PCA 3) in patients with suspected prostate cancer
    Wong, Alex Hie Lin
    Attar, Hama
    Gelister, James
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A135 - A136
  • [43] Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy EDITORIAL COMMENT
    Marks, Leonard S.
    JOURNAL OF UROLOGY, 2013, 190 (02): : 501 - 501
  • [44] Prostate cancer 3 (PCA3) represents a clinically meaningful predictor of prostate cancer at repeat biopsy
    Haese, Alexander
    Chun, Felix K. H.
    de la Taille, Alexandre
    van Poppel, Hendrik
    Marberger, Michael
    Mulders, Peter F.
    Abbou, Clement-Claude C.
    Stenzl, Amulf
    Huland, Hartwig
    Tinzl, Martina
    Remzi, Mesut
    Feyerabend, Suzan
    Van Gils, Martijn
    Stillebroer, Alexander
    Schalken, Jack A.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 724 - 725
  • [45] Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy
    Ochiai, Atsushi
    Okihara, Koji
    Kamoi, Kazumi
    Oikawa, Takehiro
    Shimazui, Toru
    Murayama, Shin-Ichiro
    Tomita, Kyoichi
    Umekawa, Tohru
    Uemura, Hirotsugu
    Miki, Tsuneharu
    BJU INTERNATIONAL, 2013, 111 (06) : 928 - 933
  • [46] Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies
    Scattoni, V
    Lazzeri, M.
    De Luca, S.
    Bollito, E.
    Randone, D.
    Lughezzani, G.
    Larcher, A.
    Lista, G.
    Gadda, G.
    Maccagnano, C.
    Rigatti, P.
    Guazzoni, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E912 - U917
  • [47] PCA3 is a true oncomarker of prostate cancer: a review of literature
    Sidorenkov, A. V.
    Pushkar, D. Yu.
    ONKOUROLOGIYA, 2014, 10 (02): : 70 - 77
  • [48] PSA, PCA3 and the phi losophy of prostate cancer management
    Melichar, Bohuslav
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (04) : 707 - 712
  • [49] Specificity of PCA3 molecular urine test for prostate cancer
    Groskopf, J.
    Deras, I.
    Walker, S.
    Blase, A.
    Desaulniers, M.
    Fradet, Y.
    Marks, L. S.
    Rittenhouse, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 665 - 666
  • [50] Value of urinary PCA3 test for prostate cancer diagnosis
    Vlaeminck-Guillem, V.
    Ruffion, A.
    Andre, J.
    PROGRES EN UROLOGIE, 2008, 18 (05): : 259 - 265
12345